{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T03:34:26Z","timestamp":1763436866978,"version":"3.40.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,21]]},"DOI":"10.7759\/cureus.82711","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T16:05:57Z","timestamp":1745251557000},"source":"Crossref","is-referenced-by-count":1,"title":["Cannabis and Dermatological Implications: A Traditional Review of Adverse Cutaneous Reactions and Systemic Risks"],"prefix":"10.7759","author":[{"given":"Shitij","family":"Shrivastava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashwat","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyam","family":"Mahaju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2018.01969","article-title":"The case for the entourage effect and conventional breeding of clinical cannabis: no \u201cstrain,\u201d no gain","volume":"9","author":"Russo EB","year":"2018","unstructured":"Russo EB. The case for the entourage effect and conventional breeding of clinical cannabis: no \u201cstrain,\u201d no gain. Front Plant Sci. 2018, 9:1969. 10.3389\/fpls.2018.01969","journal-title":"Front Plant Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI64628","article-title":"Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes","volume":"124","author":"Ol\u00e1h A","year":"2014","unstructured":"Ol\u00e1h A, T\u00f3th BI, Borb\u00edr\u00f3 I, et al.. Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes. J Clin Invest. 2014, 124:3713-24. 10.1172\/JCI64628","journal-title":"J Clin Invest"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0755-4982(04)72378-7","article-title":"[Progressive cannabis-induced arteritis: a clinical thromboangiitis obliterans sub-group?] (Article in French)","volume":"33","author":"Karila L","year":"2004","unstructured":"Karila L, Danel T, Coscas S, Chambon JP, Reynaud M. [Progressive cannabis-induced arteritis: a clinical thromboangiitis obliterans sub-group?] (Article in French). Presse Med. 2004, 33:21-3. 10.1016\/s0755-4982(04)72378-7","journal-title":"Presse Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-015-0352-z","article-title":"Cannabis allergy: what do we know anno 2015","volume":"63","author":"Decuyper I","year":"2015","unstructured":"Decuyper I, Ryckebosch H, Van Gasse AL, Sabato V, Faber M, Bridts CH, Ebo DG. Cannabis allergy: what do we know anno 2015. Arch Immunol Ther Exp (Warsz). 2015, 63:327-32. 10.1007\/s00005-015-0352-z","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.881617","article-title":"Case report: cannabidiol-induced skin rash: a case series and key recommendations","volume":"13","author":"Souza JD","year":"2022","unstructured":"Souza JD, Fassoni-Ribeiro M, Batista RM, et al.. Case report: cannabidiol-induced skin rash: a case series and key recommendations. Front Pharmacol. 2022, 13:881617. 10.3389\/fphar.2022.881617","journal-title":"Front Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3201\/eid2606.191570","article-title":"Cannabis use and fungal infections in a commercially insured population, United States, 2016","volume":"26","author":"Benedict K","year":"2020","unstructured":"Benedict K, Thompson GR 3rd, Jackson BR. Cannabis use and fungal infections in a commercially insured population, United States, 2016. Emerg Infect Dis. 2020, 26:1308-10. 10.3201\/eid2606.191570","journal-title":"Emerg Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032111","article-title":"Review of systemic and syndromic complications of cannabis use: a review","volume":"101","author":"Shah J","year":"2022","unstructured":"Shah J, Fermo O. Review of systemic and syndromic complications of cannabis use: a review. Medicine (Baltimore). 2022, 101:e32111. 10.1097\/MD.0000000000032111","journal-title":"Medicine (Baltimore)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ph15020210","article-title":"Cannabis-based products for the treatment of skin inflammatory diseases: a timely review","volume":"15","author":"Martins AM","year":"2022","unstructured":"Martins AM, Gomes AL, Vilas Boas I, Marto J, Ribeiro HM. Cannabis-based products for the treatment of skin inflammatory diseases: a timely review. Pharmaceuticals (Basel). 2022, 15:10.3390\/ph15020210","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.02.056","article-title":"The role of cannabinoids in dermatology","volume":"77","author":"Mounessa JS","year":"2017","unstructured":"Mounessa JS, Siegel JA, Dunnick CA, Dellavalle RP. The role of cannabinoids in dermatology. J Am Acad Dermatol. 2017, 77:188-90. 10.1016\/j.jaad.2017.02.056","journal-title":"J Am Acad Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/BF02862859","article-title":"An archaeological and historical account of cannabis in China","volume":"28","author":"Li HL","year":"1973","unstructured":"Li HL. An archaeological and historical account of cannabis in China. Econ Bot. 1973, 28:437-48. 10.1007\/BF02862859","journal-title":"Econ Bot"},{"key":"ref11","article-title":"Cannabis: A History","author":"Booth M","year":"2003","unstructured":"Booth M. Cannabis: A History. Picador, New York; 2003."},{"key":"ref12","article-title":"The Use of the Cannabis Drugs in India","author":"Chopra IC","year":"1957","unstructured":"Chopra IC, Chopra RN. The Use of the Cannabis Drugs in India. United Nations Office on Drugs and Crime, 1957."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.200790152","article-title":"Human cannabinoid pharmacokinetics","volume":"4","author":"Huestis MA","year":"2007","unstructured":"Huestis MA. Human cannabinoid pharmacokinetics. Chem Biodivers. 2007, 4:1770-804. 10.1002\/cbdv.200790152","journal-title":"Chem Biodivers"},{"key":"ref14","article-title":"Stability, transfer and absorption of cannabinoid constituents of cannabis (hashish) during smoking","volume":"8","author":"Agurell S","year":"1971","unstructured":"Agurell S, Leander K. Stability, transfer and absorption of cannabinoid constituents of cannabis (hashish) during smoking. Acta Pharm Suec. 1971, 8:391-402.","journal-title":"Acta Pharm Suec"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1984.tb04376.x","article-title":"Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin","volume":"36","author":"Law B","year":"1984","unstructured":"Law B, Mason PA, Moffat AC, Gleadle RI, King LJ. Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin. J Pharm Pharmacol. 1984, 36:289-94. 10.1111\/j.2042-7158.1984.tb04376.x","journal-title":"J Pharm Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1980.181","article-title":"Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking","volume":"28","author":"Ohlsson A","year":"1980","unstructured":"Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK. Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther. 1980, 28:409-16. 10.1038\/clpt.1980.181","journal-title":"Clin Pharmacol Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett AC","year":"2002","unstructured":"Howlett AC, Barth F, Bonner TI, et al.. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev. 2002, 54:161-202. 10.1124\/pr.54.2.161","journal-title":"Pharmacol Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.01.033","article-title":"Cannabidiol, neuroprotection and neuropsychiatric disorders","volume":"112","author":"Campos AC","year":"2016","unstructured":"Campos AC, Foga\u00e7a MV, Sonego AB, Guimar\u00e3es FS. Cannabidiol, neuroprotection and neuropsychiatric disorders. Pharmacol Res. 2016, 112:119-27. 10.1016\/j.phrs.2016.01.033","journal-title":"Pharmacol Res"},{"key":"ref19","article-title":"Key Substance Use and Mental Health Indicators in the United States: Results From the 2019 National Survey on Drug Use and Health","year":"2020","unstructured":"Key Substance Use and Mental Health Indicators in the United States. Results From the 2019 National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration, Rockville, MD; 2020."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2015.1858","article-title":"Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013","volume":"72","author":"Hasin DS","year":"2015","unstructured":"Hasin DS, Saha TD, Kerridge BT, et al.. Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA Psychiatry. 2015, 72:1235-42. 10.1001\/jamapsychiatry.2015.1858","journal-title":"JAMA Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(14)00117-5","article-title":"Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study","volume":"2","author":"Di Forti M","year":"2015","unstructured":"Di Forti M, Marconi A, Carra E, et al.. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. Lancet Psychiatry. 2015, 2:233-8. 10.1016\/S2215-0366(14)00117-5","journal-title":"Lancet Psychiatry"},{"key":"ref22","article-title":"Cannabis use during pregnancy and postpartum","volume":"66","author":"Badowski S","year":"2020","unstructured":"Badowski S, Smith G. Cannabis use during pregnancy and postpartum. Can Fam Physician. 2020, 66:98-103.","journal-title":"Can Fam Physician"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/all.15237","article-title":"Cannabis-related allergies: an international overview and consensus recommendations","volume":"77","author":"Skypala IJ","year":"2022","unstructured":"Skypala IJ, Jeimy S, Brucker H, et al.. Cannabis-related allergies: an international overview and consensus recommendations. Allergy. 2022, 77:2038-52. 10.1111\/all.15237","journal-title":"Allergy"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.12.516","article-title":"Cannabis hypersensitivity prevalence and presentation - a survey-based study of an allergic adult population in a Toronto clinic at onset of Canadian legalization of recreational marijuana","volume":"145","author":"Lo SC","year":"2020","unstructured":"Lo SC, Abbaslou M, Abbas K, Kobric D, Silvers W, Sussman G. Cannabis hypersensitivity prevalence and presentation - a survey-based study of an allergic adult population in a Toronto clinic at onset of Canadian legalization of recreational marijuana. J Allergy Clin Immunol. 2020, 145:AB129. 10.1016\/j.jaci.2019.12.516","journal-title":"J Allergy Clin Immunol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1943.s1-23.3","article-title":"Poisonous and injurious plants of Panama","volume":"23","author":"Allen PH","year":"1943","unstructured":"Allen PH. Poisonous and injurious plants of Panama. Amer J Trop Med. 1943, 23:3-76. 10.4269\/ajtmh.1943.s1-23.3","journal-title":"Amer J Trop Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2013.04.018","article-title":"Characterization of Cannabis sativa allergens","volume":"111","author":"Nayak AP","year":"2013","unstructured":"Nayak AP, Green BJ, Sussman G, et al.. Characterization of Cannabis sativa allergens. Ann Allergy Asthma Immunol. 2013, 111:32-7. 10.1016\/j.anai.2013.04.018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1159\/000115887","article-title":"Sensitization and allergy to Cannabis sativa leaves in a population of tomato (Lycopersicon esculentum)-sensitized patients","volume":"146","author":"de Larramendi CH","year":"2008","unstructured":"de Larramendi CH, Carn\u00e9s J, Garc\u00eda-Abujeta JL, et al.. Sensitization and allergy to Cannabis sativa leaves in a population of tomato (Lycopersicon esculentum)-sensitized patients. Int Arch Allergy Immunol. 2008, 146:195-202. 10.1159\/000115887","journal-title":"Int Arch Allergy Immunol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1159\/000351068","article-title":"Prevalence of sensitization to Cannabis sativa. Lipid-transfer and thaumatin-like proteins are relevant allergens","volume":"162","author":"Larramendi CH","year":"2013","unstructured":"Larramendi CH, L\u00f3pez-Matas M\u00c1, Ferrer A, et al.. Prevalence of sensitization to Cannabis sativa. Lipid-transfer and thaumatin-like proteins are relevant allergens. Int Arch Allergy Immunol. 2013, 162:115-22. 10.1159\/000351068","journal-title":"Int Arch Allergy Immunol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2015.01.004","article-title":"Cannabis sativa: the unconventional \"weed\" allergen","volume":"114","author":"Ocampo TL","year":"2015","unstructured":"Ocampo TL, Rans TS. Cannabis sativa: the unconventional \"weed\" allergen. Ann Allergy Asthma Immunol. 2015, 114:187-92. 10.1016\/j.anai.2015.01.004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2007.01169.x","article-title":"Work-related contact urticaria to Cannabis sativa","volume":"58","author":"Williams C","year":"2008","unstructured":"Williams C, Thompstone J, Wilkinson M. Work-related contact urticaria to Cannabis sativa. Contact Dermatitis. 2008, 58:62-3. 10.1111\/j.1600-0536.2007.01169.x","journal-title":"Contact Dermatitis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.05318.x","article-title":"Cannabis-induced erythema multiforme-like recurrent drug eruption","volume":"53","author":"Ozyurt S","year":"2014","unstructured":"Ozyurt S, Muderrisoglu F, Ermete M, Afsar F. Cannabis-induced erythema multiforme-like recurrent drug eruption. Int J Dermatol. 2014, 53:e22-3. 10.1111\/j.1365-4632.2011.05318.x","journal-title":"Int J Dermatol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0528.1993.tb00725.x","article-title":"Effects of cannabis smoking on oral soft tissues","volume":"21","author":"Darling MR","year":"1993","unstructured":"Darling MR, Arendorf TM. Effects of cannabis smoking on oral soft tissues. Community Dent Oral Epidemiol. 1993, 21:78-81. 10.1111\/j.1600-0528.1993.tb00725.x","journal-title":"Community Dent Oral Epidemiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1834-7819.2005.tb00343.x","article-title":"General and oral health implications of cannabis use","volume":"50","author":"Cho CM","year":"2005","unstructured":"Cho CM, Hirsch R, Johnstone S. General and oral health implications of cannabis use. Aust Dent J. 2005, 50:70-4. 10.1111\/j.1834-7819.2005.tb00343.x","journal-title":"Aust Dent J"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1990.tb00852.x","article-title":"Effect of cannabis use on oral candidal carriage","volume":"19","author":"Darling MR","year":"1990","unstructured":"Darling MR, Arendorf TM, Coldrey NA. Effect of cannabis use on oral candidal carriage. J Oral Pathol Med. 1990, 19:319-21. 10.1111\/j.1600-0714.1990.tb00852.x","journal-title":"J Oral Pathol Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2017.26.53.11694","article-title":"Cannabis arteritis","volume":"26","author":"El Omri N","year":"2017","unstructured":"El Omri N, Eljaoudi R, Mekouar F, Jira M, Sekkach Y, Amezyane T, Ghafir D. Cannabis arteritis. Pan Afr Med J. 2017, 26:53. 10.11604\/pamj.2017.26.53.11694","journal-title":"Pan Afr Med J"},{"key":"ref36","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3565(25)30459-3","article-title":"Vasoconstrictor actions of delta8- and delta9-tetrahydrocannabinol in the rat","volume":"196","author":"Adams MD","year":"1976","unstructured":"Adams MD, Earnhardt JT, Dewey WL, Harris LS . Vasoconstrictor actions of delta8- and delta9-tetrahydrocannabinol in the rat. J Pharmacol Exp Ther . 1976, 196:649-56.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/BF01246877","article-title":"Ultrastructural alterations and environmental exposure influence the opiate concentrations in hair of drug addicts","volume":"107","author":"P\u00f6tsch L","year":"1995","unstructured":"P\u00f6tsch L, Skopp G, Becker J. Ultrastructural alterations and environmental exposure influence the opiate concentrations in hair of drug addicts. Int J Legal Med. 1995, 107:301-5. 10.1007\/BF01246877","journal-title":"Int J Legal Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.3.430","article-title":"Acute generalized exanthematous pustulosis caused by illicit street drugs?","volume":"143","author":"Lu LK","year":"2007","unstructured":"Lu LK, High WA. Acute generalized exanthematous pustulosis caused by illicit street drugs?. Arch Dermatol. 2007, 143:430-1. 10.1001\/archderm.143.3.430","journal-title":"Arch Dermatol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-015-0158-0","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: an update","volume":"16","author":"Dodiuk-Gad RP","year":"2015","unstructured":"Dodiuk-Gad RP, Chung WH, Valeyrie-Allanore L, Shear NH. Stevens-Johnson syndrome and toxic epidermal necrolysis: an update. Am J Clin Dermatol. 2015, 16:475-93. 10.1007\/s40257-015-0158-0","journal-title":"Am J Clin Dermatol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39454","article-title":"Weeding out the culprit: cannabinoid-associated Stevens-Johnson syndrome","volume":"15","author":"Li J","year":"2023","unstructured":"Li J, Miller M, Abu Khalaf S, Nelson TB. Weeding out the culprit: cannabinoid-associated Stevens-Johnson syndrome. Cureus. 2023, 15:e39454. 10.7759\/cureus.39454","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/343619-cannabis-and-dermatological-implications-a-traditional-review-of-adverse-cutaneous-reactions-and-systemic-risks","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T16:05:58Z","timestamp":1745251558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/343619-cannabis-and-dermatological-implications-a-traditional-review-of-adverse-cutaneous-reactions-and-systemic-risks"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":40,"URL":"https:\/\/doi.org\/10.7759\/cureus.82711","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,21]]}}}